OMC

OUP Management Company Portfolio holdings

AUM $44.5M
This Quarter Return
+21.06%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$61.3M
AUM Growth
+$61.3M
Cap. Flow
-$8.32M
Cap. Flow %
-13.59%
Top 10 Hldgs %
96.86%
Holding
16
New
1
Increased
–
Reduced
2
Closed
2

Top Buys

1
PRME icon
Prime Medicine
PRME
$2.25M

Top Sells

1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$8.37M
2
EVLV icon
Evolv Technologies
EVLV
$1.38M
3
LABP
Landos Biopharma, Inc. Common Stock
LABP
$804K
4
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
$16.5K

Sector Composition

1 Healthcare 93.37%
2 Technology 6.63%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JBIO
1
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$17.7M 28.88%
603,762
– –
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.25B
$9.11M 14.87%
2,937,615
– –
PMVP icon
3
PMV Pharmaceuticals
PMVP
$74.2M
$8.61M 14.05%
989,232
– –
DICE
4
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$8.37M 13.67%
268,346
-268,347
-50% -$8.37M
IONQ icon
5
IonQ
IONQ
$12.7B
$4.06M 6.63%
1,177,597
– –
CYT
6
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$4.06M 6.63%
2,459,572
-10,000
-0.4% -$16.5K
VOR icon
7
Vor Biopharma
VOR
$250M
$2.49M 4.07%
374,714
– –
PRME icon
8
Prime Medicine
PRME
$578M
$2.25M 3.68%
+121,255
New +$2.25M
LENZ
9
LENZ Therapeutics
LENZ
$1.1B
$1.35M 2.2%
406,308
– –
DTIL icon
10
Precision BioSciences
DTIL
$57.8M
$1.34M 2.18%
1,123,913
– –
RNAC icon
11
Cartesian Therapeutics
RNAC
$261M
$975K 1.59%
862,543
– –
EFTR
12
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$439K 0.72%
1,025,697
– –
SPRO icon
13
Spero Therapeutics
SPRO
$116M
$431K 0.7%
249,070
– –
QTTB icon
14
Q32 Bio
QTTB
$20.9M
$80.6K 0.13%
64,000
– –
EVLV icon
15
Evolv Technologies
EVLV
$1.42B
– –
-652,475
Closed -$1.38M
LABP
16
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
– –
-1,237,667
Closed -$804K